Early detection of neoplastic lesions before the onset of clinical symptoms exponentially increases curative treatment success rates, preserves functional anatomy, and significantly reduces healthcare costs. Our Comprehensive Multi-Organ Cancer Screening Package provides a systematic, whole-body oncological assessment.
Multi-Organ Screening Targets
- Thyroid Gland: High-resolution ultrasound with ACR TI-RADS risk classification and serum TSH.
- Breast (Females): Bilateral breast ultrasonography for early microcalcifications and nodular lesions.
- Cervix & Uterus (Females): Liquid-based cervical cytology (ThinPrep) and high-risk HPV DNA genotyping.
- Liver & Biliary Tract: Serum Alpha-Fetoprotein (AFP) combined with high-resolution abdominal sonography.
- Gastrointestinal Tract: Carcinoembryonic Antigen (CEA) and high-definition video endoscopy recommendations.
- Pancreas & Biliary Tree: Serum CA 19-9 biomarker quantification and pancreatic ultrasound evaluation.
- Prostate (Males): Total Prostate-Specific Antigen (Total PSA) and transabdominal prostatic sonography.
- Lungs & Respiratory System: Digital low-dose chest radiography and clinical pulmonary consultation.
Integrated Specialist Review
Screening results are synthesized into a comprehensive medical report by experienced clinicians, accompanied by personalized lifestyle guidance, risk stratification, and structured surveillance schedules.
